We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$710M
AUM Growth
-$45.7M
Cap. Flow
-$39.7M
Cap. Flow %
-5.59%
Top 10 Hldgs %
9.53%
Holding
2,469
New
584
Increased
596
Reduced
458
Closed
638

Sector Composition

Rank Sector Weight
1 Technology 11.11%
2 Energy 9.76%
3 Consumer Discretionary 8.51%
4 Industrials 8.43%
5 Healthcare 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JMBA
1251
DELISTED
Jamba, Inc.
JMBA
$70K 0.01%
4,900
+1,400
+40% +$18.9K
BAX icon
1252
Baxter International
BAX
$14.2B
$69K 0.01%
1,767
+603
+52% +$24.5K
BLDR icon
1253
Builders FirstSource
BLDR
$8.04B
$69K 0.01%
12,600
-9,500
-43% -$61.9K
DG icon
1254
Dollar General
DG
$27.9B
$69K 0.01%
+1,122
New +$67.2K
VFC icon
1255
VF Corp
VFC
$5.89B
$69K 0.01%
+1,104
New +$66K
XRAY icon
1256
Dentsply Sirona
XRAY
$2.43B
$69K 0.01%
1,507
+573
+61% +$27K
HIL
1257
DELISTED
Hill International, Inc. Common Stock
HIL
$69K 0.01%
+17,300
New +$84.1K
KERX
1258
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$69K 0.01%
5,000
-200
-4% -$3.06K
YELL
1259
DELISTED
Yellow Corporation Common Stock
YELL
$69K 0.01%
3,400
+2,290
+206% +$54.8K
CYTK icon
1260
Cytokinetics
CYTK
$10.4B
$68K 0.01%
19,250
+6,700
+53% +$28.1K
DOV icon
1261
Dover
DOV
$28.4B
$68K 0.01%
+1,052
New +$74K
MGM icon
1262
CALL
MGM Resorts International
MGM
$11.2B
$68K 0.01%
3,000
+500
+20% +$12.4K
PNC icon
1263
PNC Financial Services
PNC
$101B
$68K 0.01%
800
SRPT icon
1264
Sarepta Therapeutics
SRPT
$1.77B
$68K 0.01%
3,200
+2,200
+220% +$49.7K
WWE
1265
DELISTED
World Wrestling Entertainment
WWE
$68K 0.01%
4,970
-17,197
-78% -$233K
MBVT
1266
DELISTED
Merchants Bancshares Inc
MBVT
$68K 0.01%
2,400
+800
+50% +$23.7K
CFN
1267
DELISTED
CAREFUSION CORPORATION
CFN
$68K 0.01%
1,497
+487
+48% +$21.9K
BALL icon
1268
Ball Corp
BALL
$16.8B
$67K 0.01%
2,104
+702
+50% +$22.4K
BDX icon
1269
Becton Dickinson
BDX
$48.2B
$67K 0.01%
602
+222
+58% +$25.3K
BBBY
1270
Bed Bath & Beyond
BBBY
$442M
$67K 0.01%
+5,324
New +$67.3K
GIC icon
1271
Global Industrial
GIC
$1.49B
$67K 0.01%
5,400
-4,600
-46% -$64.5K
RICK icon
1272
RCI Hospitality Holdings
RICK
$215M
$67K 0.01%
6,100
-1,900
-24% -$21.6K
XLU icon
1273
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
$67K 0.01%
+3,200
New +$67.8K
DD icon
1274
DuPont de Nemours
DD
$19.2B
$66K 0.01%
494
MCHX icon
1275
Marchex
MCHX
$79.7M
$66K 0.01%
15,800
+8,900
+129% +$82.8K

Similar funds

Prelude Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Prelude Capital Management held 2,469 positions worth $710M, down 6% from $756M the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Prelude Capital Management withdrew a net $39.7M in Q3 2014, closing 638 positions and reducing 458 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $5.64M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.1% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in CONCUR TECHNOLOGIES INC worth $6.4M.

  • Prelude Capital Management's largest Q3 2014 buy was CONCUR TECHNOLOGIES INC: 50,447 shares worth $6.4M.
  • Prelude Capital Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2014, an estimated $6.42M increase.
  • Prelude Capital Management's biggest Q3 2014 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $4.48M.
  • Prelude Capital Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $5.64M.
  • Prelude Capital Management's ten largest holdings make up 9.5% of its $710M portfolio in Q3 2014.
  • Prelude Capital Management opened 584 new positions and closed 638 in Q3 2014.
  • Prelude Capital Management's portfolio value fell 6% quarter-over-quarter to $710M.

Based on Prelude Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.